Lexaria Bioscience announces a $3.6 million offering and private placement to enhance operational capabilities and drive innovation in the pharmaceutical ...
Discover how nanoporous membranes are revolutionizing water filtration. A recent study reveals the importance of nanopore placement for optimal performance. ...
Teva completes enrollment for Phase 3 trial of mdc-TJK, a potential treatment for schizophrenia. Results expected in 2024. #schizophrenia #clinicaltrials